You have printed or saved this information from www.NATI.net, the website for the Newfoundland and Labrador Association of Technology Industries.

 

SequenceBio CEO Dr. Tyler Wish Addressing Delegates on Industry Panel at Precision Medicine World Conference

Posted Tuesday, January 26, 2016

(Silicon Valley, California)  - Dr. Tyler Wish, CEO of SequenceBio, will share insight on the 100,000 patient initiative the company has in progress in Newfoundland and Labrador at The Personalized Medicine World Conference (PMWC) as part of a panel on Generating Data-Driven Insight in Personalized Medicine at this week's event. Joining Dr. Wish on the Panel, moderated by Mick Correll of Genospace, a partner of SequenceBio, are fellow panelists Mathias Ehrich, Sequenom and Aaron Black, Inova. SequenceBio is the only Canadian company presenting and speaking at PMWC.

"PMWC is a global event, attracting the world's best thinkers, leaders and players in the biotech industry. Precision medicine is positioned to improve patient outcomes around the world. Our event is truly forward thinking and collaborative - we are pleased to have Dr. Wish, SequenceBio CEO,  share news from Newfoundland and Labrador on how generating insight with data will vastly improve populations in the province and within the Canadian health care space", Tal Behar,  ‎Co-founder & President, PMWC International.

PMWC is an independent and established conference that attracts recognized authorities and experts across healthcare and biotechnology sectors. The Conference showcases practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional collaboration to further adoption of personalized medicine in the clinic.

"The cross-disciplinary nature of the event makes PMWC a fantastic venue to highlight the innovative ways that our partners and collaborators like SequenceBio are deriving insights from their precision medicine programs in order to improve patient outcomes", said Mick Correll, CEO of Genospace.

Major international players, including Stanford Health Care, Oracle Health Sciences and UCSF attend PMWC, an event that began in 2009 in the Silicon Valley. Satellite conferences happen globally, notably in the United Kingdom and Israel.

SequenceBio is a biotechnology company leading a 100,000 person population sequencing initiative in the Province of Newfoundland & Labrador. The initiative will generate a uniquely powerful dataset of genomic and phenotypic information that SequenceBIo will use for computational drug discovery and to empower better patient care. SequenceBio is committed to working with participants, collaborators and partners to enable innovation that enhances the lives of patients, families and communities in Newfoundland & Labrador and around the world. Visit www.sequencebio.co for additional corporate, investor and participant information.


Media Contact:

Karen Moores
Vice President, Communications and Public Affairs
karen@sequencebio.co
709.697.0734